The maximum solubility of TFMB-R-2HG (867 mM in DMSO) prevents its application at the high millimolar concentrations that are physiologically relevant for IDH-mutant gliomas (up to 30 mM) (5, 22). The gene discussed is IDH2; the disease is central nervous system cancer.